Comment on Sanjay Kalra et al (J Pak Med Assoc. 2017; 5: 810-813) Diabetes mellitus, malaria and HbA1c levels

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F17%3A10373527" target="_blank" >RIV/00216208:11130/17:10373527 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064203:_____/17:10373527 RIV/00216208:11120/17:43915719

Výsledek na webu

<a href="http://jpma.org.pk/full_article_text.php?article_id=8463" target="_blank" >http://jpma.org.pk/full_article_text.php?article_id=8463</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Comment on Sanjay Kalra et al (J Pak Med Assoc. 2017; 5: 810-813) Diabetes mellitus, malaria and HbA1c levels

Popis výsledku v původním jazyce

We have read with great interest the review by Kalra S. et al. published in the May 2017 issue of JPMA which focuses on various aspects of the relationship between malaria and diabetes mellitus. We wonder whether the authors, while carrying out their search, have come across a communication dealing with kinetics of HbA1c changes in diabetic patients affected by malaria. We assume that episodes of red blood cells destruction especially if resulting in anaemia and subsequent accelerated haematopoiesis (not to mention possible blood transfusions) resulting from malaria which disrupt the long-term stable red blood cell turnover could potentially lead to a false HbA1c values not corresponding to the real level of diabetes metabolic control. Changes in the treatment of diabetes mellitus, based on the HbA1c value obtained in such a situation, would not reflect the real glycaemic values in the period before it was determined. Provided this assumption is correct, then changes in antidiabetic medication in diabetic patients with malaria, particularly in its chronic form, should be performed with greater accentuation of structured self-monitoring of glycaemia than usual.

Název v anglickém jazyce

Comment on Sanjay Kalra et al (J Pak Med Assoc. 2017; 5: 810-813) Diabetes mellitus, malaria and HbA1c levels

Popis výsledku anglicky

We have read with great interest the review by Kalra S. et al. published in the May 2017 issue of JPMA which focuses on various aspects of the relationship between malaria and diabetes mellitus. We wonder whether the authors, while carrying out their search, have come across a communication dealing with kinetics of HbA1c changes in diabetic patients affected by malaria. We assume that episodes of red blood cells destruction especially if resulting in anaemia and subsequent accelerated haematopoiesis (not to mention possible blood transfusions) resulting from malaria which disrupt the long-term stable red blood cell turnover could potentially lead to a false HbA1c values not corresponding to the real level of diabetes metabolic control. Changes in the treatment of diabetes mellitus, based on the HbA1c value obtained in such a situation, would not reflect the real glycaemic values in the period before it was determined. Provided this assumption is correct, then changes in antidiabetic medication in diabetic patients with malaria, particularly in its chronic form, should be performed with greater accentuation of structured self-monitoring of glycaemia than usual.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30202 - Endocrinology and metabolism (including diabetes, hormones)

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

JPMA: Journal of the Pakistan Medical Association

ISSN

0030-9982

e-ISSN

—

Svazek periodika

67

Číslo periodika v rámci svazku

11

Stát vydavatele periodika

PK - Pákistánská islámská republika

Počet stran výsledku

1

Strana od-do

—

Kód UT WoS článku

000418462000040

EID výsledku v databázi Scopus

2-s2.0-85030986823